New weekly shot aims to tackle obesity and diabetes
NCT ID NCT06151964
Summary
This study is testing the safety and effects of a new weekly injection called AZD9550, both by itself and combined with another drug, AZD6234. It involves about 118 adults who are overweight or have obesity, some with and some without type 2 diabetes. The main goals are to see how safe the drugs are, how the body processes them, and if they help with weight loss and blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Graz, 8036, Austria
-
Research Site
Vienna, 1090, Austria
-
Research Site
Surrey, British Columbia, V3T 2V6, Canada
-
Research Site
Sarnia, Ontario, N7T 4X3, Canada
-
Research Site
Stouffville, Ontario, L4A 1H2, Canada
-
Research Site
Toronto, Ontario, M4G 3E8, Canada
-
Research Site
Toronto, Ontario, M4J 5B9, Canada
-
Research Site
Sherbrooke, Quebec, J1L 0H8, Canada
-
Research Site
Magdeburg, 39120, Germany
-
Research Site
Neu-Ulm, 89231, Germany
-
Research Site
Neuss, 41460, Germany
-
Research Site
Fukuoka, 812-0025, Japan
-
Research Site
Shinjuku-ku, 160-0004, Japan
-
Research Site
Suita-shi, 565-0853, Japan
-
Research Site
Uppsala, 752 37, Sweden
Conditions
Explore the condition pages connected to this study.